Kasamon, Y L <br/><br/>
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jun 2010 
 - 1203-1210 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdp484  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--administration & dosage<br/>Combined Modality Therapy<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Immune System--physiology<br/>Immunotherapy<br/>Lymphoma--immunology<br/>Lymphoma, Mantle-Cell--immunology<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Recovery of Function--immunology<br/>Rituximab<br/>Stem Cell Transplantation--methods<br/>Transplantation Immunology<br/>Transplantation, Autologous